4th Quarter - Report

SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE

Firm
Client
Income
—
Expenses
$20,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

American Health Care Act, Best Care Reconciliation Act, Preventing Maternal Deaths Act (HR 1318/), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act, Improving Access to Maternity Care Act (S. 783, HR 315), Children's Health Insurance Program; prenatal screening, pregnancy research.

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 783 (115th), S. 1112 (115th), H.R. 1318 (115th), H.R. 315 (115th)

Budget/Appropriations BUD

Labor-HHS-Education Appropriations bill FY2018, FDA funding, maternal-fetal medicine research; sequestration and non-defense discretionary funding; maternal mental health; opioids; family planning/Title X; Zika; pre-term birth; pregnancy surveillance; reproductive health service; health services research.

LobbyistCovered position, as disclosed
KATHRYN SCHUBERT —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.